{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:45:49Z","timestamp":1785789949214,"version":"3.56.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Government of Fuqing City","award":["2019B003"],"award-info":[{"award-number":["2019B003"]}]},{"name":"Special funds of Fujian Provincial Finance Department","award":["2020czbz01"],"award-info":[{"award-number":["2020czbz01"]}]},{"name":"High-level Talents Research Start-up Project of Fujian Medical University","award":["XRCZX2017035, XRCZX2020034 and XRCZX2023030"],"award-info":[{"award-number":["XRCZX2017035, XRCZX2020034 and XRCZX2023030"]}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2017YFC0907102"],"award-info":[{"award-number":["2017YFC0907102"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-025-02704-5","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T10:56:49Z","timestamp":1760353009000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Associations between metabolic dysfunction-associated fatty liver disease and carotid and femoral atherosclerosis: a population-based cross-sectional study"],"prefix":"10.1186","volume":"24","author":[{"given":"Zhenzhen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruotian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruimei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"issue":"12","key":"2704_CR1","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3345\/cep.2022.01312","volume":"66","author":"K Song","year":"2023","unstructured":"Song K, Kim HS, Chae HW. Nonalcoholic fatty liver disease and insulin resistance in children. Clin Exp Pediatr. 2023;66(12):512\u20139.","journal-title":"Clin Exp Pediatr"},{"issue":"12","key":"2704_CR2","doi-asserted-by":"publisher","DOI":"10.2196\/34809","volume":"8","author":"H Chen","year":"2022","unstructured":"Chen H, et al. The global, regional, and national burden and trends of NAFLD in 204 countries and territories: an analysis from global burden of disease 2019. JMIR Public Health Surveill. 2022;8(12):e34809.","journal-title":"JMIR Public Health Surveill"},{"issue":"4","key":"2704_CR3","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1002\/hep.30702","volume":"70","author":"F Zhou","year":"2019","unstructured":"Zhou F, et al. Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: a systematic review and meta-analysis. Hepatology. 2019;70(4):1119\u201333.","journal-title":"Hepatology"},{"issue":"7","key":"2704_CR4","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sanyal AJ, George J. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158(7):1999-2014.e1.","journal-title":"Gastroenterology"},{"issue":"1","key":"2704_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S2468-1253(20)30294-6","volume":"6","author":"G Shiha","year":"2021","unstructured":"Shiha G, et al. Redefining fatty liver disease: an international patient perspective. The Lancet Gastroenterology & Hepatology. 2021;6(1):73\u20139.","journal-title":"The Lancet Gastroenterology & Hepatology"},{"issue":"3","key":"2704_CR6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2174\/1570161115666170621075619","volume":"16","author":"N Katsiki","year":"2018","unstructured":"Katsiki N, et al. Is nonalcoholic fatty liver disease indeed the hepatic manifestation of metabolic syndrome? Curr Vasc Pharmacol. 2018;16(3):219\u201327.","journal-title":"Curr Vasc Pharmacol"},{"issue":"6","key":"2704_CR7","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1007\/s12072-022-10407-7","volume":"16","author":"H Lee","year":"2022","unstructured":"Lee H, et al. Long-term cardiovascular outcomes differ across metabolic dysfunction-associated fatty liver disease subtypes among middle-aged population. Hepatol Int. 2022;16(6):1308\u201317.","journal-title":"Hepatol Int"},{"issue":"10","key":"2704_CR8","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/j.cgh.2020.12.022","volume":"19","author":"H Lee","year":"2021","unstructured":"Lee H, et al. Metabolic dysfunction-associated fatty liver disease and incident cardiovascular disease risk: a Nationwide Cohort Study. Clin Gastroenterol Hepatol. 2021;19(10):2138-2147.e10.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"2704_CR9","doi-asserted-by":"publisher","first-page":"474","DOI":"10.4254\/wjh.v10.i7.474","volume":"10","author":"S Alkagiet","year":"2018","unstructured":"Alkagiet S, Papagiannis A, Tziomalos K. Associations between nonalcoholic fatty liver disease and ischemic stroke. World J Hepatol. 2018;10(7):474\u20138.","journal-title":"World J Hepatol"},{"issue":"3","key":"2704_CR10","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.032997","volume":"13","author":"XD Zhou","year":"2024","unstructured":"Zhou XD, et al. High-sensitivity c-reactive protein is associated with heart failure hospitalization in patients with metabolic dysfunction-associated fatty liver disease and normal left ventricular ejection fraction undergoing coronary angiography. J Am Heart Assoc. 2024;13(3):e032997.","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"2704_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22084156","volume":"22","author":"Y Sakurai","year":"2021","unstructured":"Sakurai Y, et al. Role of insulin resistance in MAFLD. Int J Mol Sci. 2021;22(8):4156.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2704_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1161\/CIRCULATIONAHA.124.070535","volume":"151","author":"NWS Chew","year":"2025","unstructured":"Chew NWS, et al. Cardiovascular-liver-metabolic health: recommendations in screening, diagnosis, and management of metabolic dysfunction-associated steatotic liver disease in cardiovascular disease via modified delphi approach. Circulation. 2025;151(1):98\u2013119.","journal-title":"Circulation"},{"issue":"3","key":"2704_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10030467","volume":"10","author":"D Niederseer","year":"2021","unstructured":"Niederseer D, et al. Nafld and cardiovascular diseases: epidemiological, mechanistic and therapeutic considerations. J Clin Med. 2021;10(3):467.","journal-title":"J Clin Med"},{"issue":"5","key":"2704_CR14","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.cgh.2014.10.008","volume":"13","author":"MS Siddiqui","year":"2015","unstructured":"Siddiqui MS, et al. Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile. Clin Gastroenterol Hepatol. 2015;13(5):1000-8.e3.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"2704_CR15","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1053\/j.gastro.2012.02.003","volume":"142","author":"K Cusi","year":"2012","unstructured":"Cusi K. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Gastroenterology. 2012;142(4):711-725.e6.","journal-title":"Gastroenterology"},{"issue":"21","key":"2704_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111629","volume":"22","author":"J Guti\u00e9rrez-Cuevas","year":"2021","unstructured":"Guti\u00e9rrez-Cuevas J, Santos A, Armendariz-Borunda J. Pathophysiological molecular mechanisms of obesity: a link between MAFLD and NASH with cardiovascular diseases. Int J Mol Sci. 2021;22(21):11629.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2704_CR17","doi-asserted-by":"publisher","first-page":"5436","DOI":"10.1007\/s00330-023-09408-3","volume":"33","author":"TP Lima","year":"2023","unstructured":"Lima TP, et al. Coronary computed tomography plaque-based scores predict long-term cardiovascular events. Eur Radiol. 2023;33(8):5436\u201345.","journal-title":"Eur Radiol"},{"issue":"5","key":"2704_CR18","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1001\/jamacardio.2024.5702","volume":"10","author":"MC Tattersall","year":"2025","unstructured":"Tattersall MC, et al. Importance of age and sex in carotid artery plaque detection and cardiovascular disease risk. JAMA Cardiol. 2025;10(5):487\u201391.","journal-title":"JAMA Cardiol"},{"issue":"20","key":"2704_CR19","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1016\/j.jacc.2022.03.352","volume":"79","author":"AN Nicolaides","year":"2022","unstructured":"Nicolaides AN, et al. Arterial ultrasound testing to predict atherosclerotic cardiovascular events. J Am Coll Cardiol. 2022;79(20):1969\u201382.","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"2704_CR20","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1016\/j.jacc.2022.03.361","volume":"79","author":"B Ibanez","year":"2022","unstructured":"Ibanez B, Garc\u00eda-Lunar I, Fuster V. The intima-media thickness age is over: the time of multiterritorial subclinical plaque quantification has come. J Am Coll Cardiol. 2022;79(20):1983\u20135.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"2704_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13519","volume":"51","author":"P Dongiovanni","year":"2021","unstructured":"Dongiovanni P, et al. Nonalcoholic fatty liver disease or metabolic dysfunction-associated fatty liver disease diagnoses and cardiovascular diseases: from epidemiology to drug approaches. Eur J Clin Invest. 2021;51(7):e13519.","journal-title":"Eur J Clin Invest"},{"key":"2704_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.968766","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, et al. Cardiovascular and renal burdens among patients with MAFLD and NAFLD in China. Front Endocrinol (Lausanne). 2022;13:968766.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"2704_CR23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.31083\/j.rcm2406157","volume":"24","author":"H Li","year":"2023","unstructured":"Li H, et al. The transition of cardiovascular disease risks from NAFLD to MAFLD. Rev Cardiovasc Med. 2023;24(6):157.","journal-title":"Rev Cardiovasc Med"},{"issue":"4","key":"2704_CR24","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.21037\/cdt.2020.03.10","volume":"10","author":"G Zhu","year":"2020","unstructured":"Zhu G, et al. Carotid plaque imaging and the risk of atherosclerotic cardiovascular disease. Cardiovasc Diagn Ther. 2020;10(4):1048\u201367.","journal-title":"Cardiovasc Diagn Ther"},{"issue":"11","key":"2704_CR25","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/hepr.13685","volume":"51","author":"T Tsutsumi","year":"2021","unstructured":"Tsutsumi T, et al. MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD: generalized estimating equation approach. Hepatol Res. 2021;51(11):1115\u201328.","journal-title":"Hepatol Res"},{"key":"2704_CR26","doi-asserted-by":"publisher","first-page":"1047794","DOI":"10.3389\/fpubh.2022.1047794","volume":"10","author":"W Su","year":"2022","unstructured":"Su W, et al. Association of metabolic dysfunction-associated fatty liver disease, type 2 diabetes mellitus, and metabolic goal achievement with risk of chronic kidney disease. Front Public Health. 2022;10:1047794.","journal-title":"Front Public Health"},{"key":"2704_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154779","volume":"120","author":"S Liu","year":"2021","unstructured":"Liu S, et al. The progression and regression of metabolic dysfunction-associated fatty liver disease are associated with the development of subclinical atherosclerosis: a prospective analysis. Metabolism. 2021;120:154779.","journal-title":"Metabolism"},{"key":"2704_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.938902","volume":"9","author":"X Wang","year":"2022","unstructured":"Wang X, et al. Liver biomarkers, genetic and lifestyle risk factors in relation to risk of cardiovascular disease in Chinese. Front Cardiovasc Med. 2022;9:938902.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"2704_CR29","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jdiacomp.2016.09.008","volume":"31","author":"K Guo","year":"2017","unstructured":"Guo K, et al. Non-alcoholic fatty liver disease is associated with late but not early atherosclerotic lesions in Chinese inpatients with type 2 diabetes. J Diabetes Complications. 2017;31(1):80\u20135.","journal-title":"J Diabetes Complications"},{"issue":"1","key":"2704_CR30","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12944-023-01947-4","volume":"22","author":"Q Liu","year":"2023","unstructured":"Liu Q, et al. Shift in prevalence and systemic inflammation levels from NAFLD to MAFLD: a population-based cross-sectional study. Lipids Health Dis. 2023;22(1):185.","journal-title":"Lipids Health Dis"},{"issue":"10","key":"2704_CR31","doi-asserted-by":"publisher","first-page":"e800","DOI":"10.1016\/S2468-2667(23)00183-4","volume":"8","author":"MN Ahmadi","year":"2023","unstructured":"Ahmadi MN, et al. Brief bouts of device-measured intermittent lifestyle physical activity and its association with major adverse cardiovascular events and mortality in people who do not exercise: a prospective cohort study. Lancet Public Health. 2023;8(10):e800\u201310.","journal-title":"Lancet Public Health"},{"issue":"1","key":"2704_CR32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12944-019-0984-9","volume":"18","author":"XY Ren","year":"2019","unstructured":"Ren XY, et al. Total cholesterol to high-density lipoprotein cholesterol ratio is a significant predictor of nonalcoholic fatty liver: Jinchang cohort study. Lipids Health Dis. 2019;18(1):47.","journal-title":"Lipids Health Dis"},{"key":"2704_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.746747","volume":"12","author":"SY Lin","year":"2021","unstructured":"Lin SY, et al. Optimal threshold of homeostasis model assessment of insulin resistance to identify metabolic syndrome in a Chinese population aged 45 years or younger. Front Endocrinol (Lausanne). 2021;12:746747.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2704_CR34","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1161\/ATVBAHA.122.318086","volume":"43","author":"Q Su","year":"2023","unstructured":"Su Q, et al. Association between serum bilirubin, lipid levels, and prevalence of femoral and carotid atherosclerosis: a population-based cross-sectional study. Arterioscler Thromb Vasc Biol. 2023;43(1):136\u201345.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"2704_CR35","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam M, et al. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158(7):1999-2014.e1.","journal-title":"Gastroenterology"},{"issue":"8","key":"2704_CR36","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.008701","volume":"7","author":"X Wang","year":"2018","unstructured":"Wang X, et al. Carotid atherosclerosis detected by ultrasonography: a national cross-sectional study. J Am Heart Assoc. 2018;7(8):e008701.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"2704_CR37","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/s12933-023-02083-0","volume":"22","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, et al. Association of metabolic dysfunction-associated fatty liver disease with systemic atherosclerosis: a community-based cross-sectional study. Cardiovasc Diabetol. 2023;22(1):342.","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"2704_CR38","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1161\/CIRCULATIONAHA.106.658948","volume":"115","author":"CS Fox","year":"2007","unstructured":"Fox CS, et al. Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Circulation. 2007;115(12):1544\u201350.","journal-title":"Circulation"},{"issue":"3","key":"2704_CR39","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s00059-016-4414-8","volume":"41","author":"RJ King","year":"2016","unstructured":"King RJ, Grant PJ. Diabetes and cardiovascular disease: pathophysiology of a life-threatening epidemic. Herz. 2016;41(3):184\u201392.","journal-title":"Herz"},{"issue":"25","key":"2704_CR40","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1161\/CIR.0000000000000343","volume":"132","author":"JG Regensteiner","year":"2015","unstructured":"Regensteiner JG, et al. Sex differences in the cardiovascular consequences of diabetes mellitus: a scientific statement from the American Heart Association. Circulation. 2015;132(25):2424\u201347.","journal-title":"Circulation"},{"key":"2704_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2024.107282","volume":"154","author":"K Solanki","year":"2024","unstructured":"Solanki K, et al. Effect of reactive oxygen, nitrogen, and sulfur species on signaling pathways in atherosclerosis. Vascul Pharmacol. 2024;154:107282.","journal-title":"Vascul Pharmacol"},{"issue":"10","key":"2704_CR42","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.2337\/db11-0194","volume":"60","author":"YS Lee","year":"2011","unstructured":"Lee YS, et al. Inflammation is necessary for long-term but not short-term high-fat diet-induced insulin resistance. Diabetes. 2011;60(10):2474\u201383.","journal-title":"Diabetes"},{"issue":"1","key":"2704_CR43","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/hep.30834","volume":"71","author":"AM Papatheodoridi","year":"2020","unstructured":"Papatheodoridi AM, et al. The role of senescence in the development of nonalcoholic fatty liver disease and progression to nonalcoholic steatohepatitis. Hepatology. 2020;71(1):363\u201374.","journal-title":"Hepatology"},{"issue":"13","key":"2704_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202306685","volume":"11","author":"Y Liu","year":"2024","unstructured":"Liu Y, et al. Macrophage CREBZF orchestrates inflammatory response to potentiate insulin resistance and type 2 diabetes. Adv Sci. 2024;11(13):e2306685.","journal-title":"Adv Sci"},{"issue":"2","key":"2704_CR45","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/1753-0407.12970","volume":"12","author":"JK Beverly","year":"2020","unstructured":"Beverly JK, Budoff MJ. Atherosclerosis: pathophysiology of insulin resistance, hyperglycemia, hyperlipidemia, and inflammation. J Diabetes. 2020;12(2):102\u20134.","journal-title":"J Diabetes"},{"issue":"6","key":"2704_CR46","first-page":"751","volume":"52","author":"Y Li","year":"2023","unstructured":"Li Y, et al. Hepatocyte steatosis activates macrophage inflammatory response accelerating atherosclerosis development. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2023;52(6):751\u201365.","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"issue":"1","key":"2704_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/j.2040-4603.2019.tb00055.x","volume":"9","author":"MS Burhans","year":"2018","unstructured":"Burhans MS, et al. Contribution of adipose tissue inflammation to the development of type 2 diabetes mellitus. Compr Physiol. 2018;9(1):1\u201358.","journal-title":"Compr Physiol"},{"issue":"5","key":"2704_CR48","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.008507","volume":"7","author":"SAE Peters","year":"2018","unstructured":"Peters SAE, Bots SH, Woodward M. Sex differences in the association between measures of general and central adiposity and the risk of myocardial infarction: results from the UK Biobank. J Am Heart Assoc. 2018;7(5):e008507.","journal-title":"J Am Heart Assoc"},{"key":"2704_CR49","doi-asserted-by":"crossref","unstructured":"Song P, Fang Z, Wang H, et al. Global and regional prevalence, burden, and risk factors for carotid atherosclerosis: a systematic review, meta-analysis, and modelling study. Lancet Glob Health. 2020;8(5):e721\u20139. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214109X20301170.","DOI":"10.1016\/S2214-109X(20)30117-0"},{"issue":"9","key":"2704_CR50","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.7150\/thno.81388","volume":"13","author":"J An","year":"2023","unstructured":"An J, et al. Nicotine exacerbates atherosclerosis and plaque instability via NLRP3 inflammasome activation in vascular smooth muscle cells. Theranostics. 2023;13(9):2825\u201342.","journal-title":"Theranostics"},{"issue":"3","key":"2704_CR51","doi-asserted-by":"publisher","first-page":"189","DOI":"10.5551\/jat.RV22015","volume":"31","author":"M Ishida","year":"2024","unstructured":"Ishida M, et al. Cigarette smoking and atherosclerotic cardiovascular disease. J Atheroscler Thromb. 2024;31(3):189\u2013200.","journal-title":"J Atheroscler Thromb"},{"issue":"7","key":"2704_CR52","doi-asserted-by":"publisher","DOI":"10.1111\/apha.14166","volume":"240","author":"G Amin","year":"2024","unstructured":"Amin G, Booz GW, Zouein FA. Lasting consequences of cigarette smoking on the heart. Acta Physiol (Oxf). 2024;240(7):e14166.","journal-title":"Acta Physiol (Oxf)"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02704-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-025-02704-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02704-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T12:08:31Z","timestamp":1760357311000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-025-02704-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2704"],"URL":"https:\/\/doi.org\/10.1186\/s12944-025-02704-5","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"assertion":[{"value":"11 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted following the principles of the Declaration of Helsinki. This study was approved by the Ethics Committee of Fujian Medical University. (Approval number [2017\u201307 and 2020\u201358]). All participants enrolled in this study provided written informed consent for the participation, storage, and use of their biological samples.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"316"}}